Seeking value primarily in developed markets worldwide

The Fund invests primarily in common and preferred stocks of United States and non-United States companies, including companies in emerging markets. Normally, the Fund invests the majority of its total assets in companies that pay dividends or otherwise seek to return capital to shareholders, such as by repurchasing their shares.

The Fund may invest up to 25% of its total assets in companies in emerging (less developed) markets, which may include investments through legal structures known as variable interest entities (“VIEs”). Under normal circumstances, the Fund will invest no more than 60% of its total assets in the United States and at least 40% of its total assets in a number of countries outside the United States. The Fund is not required to allocate its investments in any specific percentages in any particular countries.

Please see the Prospectus and Supplement for more information. Please contact [email protected] for a Fund Application.

Nav*
$11.50
Inception**
18 July 2025
ISIN
IE000HM5ME21
Benchmark
MSCI ACWI
Minimum investment
$1,000,000
Total expense ratio
0.63%
*As of 13 April 2026
**Inception for USD Accumulation RDR Share Class
Download Fact Sheet Download Prospectus
Contact Us

Strategy overview

The portfolio managers discuss our Global Value strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Month end (as of 31 March 2026)
Table Header QTD YTD Since inception
Fund (net) -6.2%-6.2%8.4%
MSCI ACWI in USD -3.1%-3.1%6.7%
Table Header QTD YTD Since inception
Fund (net) -6.2%-6.2%8.4%
MSCI ACWI in USD -3.1%-3.1%6.7%

Portfolio (as of 31 March 2026)

Benchmark: MSCI ACWI
Asset Allocation
Table Header Fund
Stocks 97.8%
Cash 2.2%
Fund Characteristics
Table Header Fund Benchmark
Holdings 54 2515
Weighted avg. market cap (US $MM) $150,873 $725,476
Price/book value 2.1 3.4
FY2 price/earnings 11.5 15.4
Net assets $272,628,849.60 -
TOP 10 HOLDINGS
Security Country Percent
Kering SA France 4.8%
Alstom SA France 3.5%
Renesas Electronics Corp. Japan 3.4%
Carrier Global Corp. United States 3.1%
SAP SE Germany 2.9%
AstraZeneca PLC United Kingdom 2.8%
Infineon Technologies AG Germany 2.8%
Merck & Co., Inc. United States 2.7%
Alphabet, Inc. United States 2.5%
Alaska Air Group, Inc. United States 2.4%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator. Data is from the Investment Adviser’s accounting system and will differ from the Fund’s official net asset value for reasons including: differences in the accrual of certain expenses, income, and recognition of cash flows, and fund holidays.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Fund Benchmark
Industrials 17.9% 11.3%
Information Technology 17.1% 26.4%
Financials 15.0% 16.9%
Health Care 12.8% 8.9%
Consumer Discretionary 11.8% 9.4%
Communication Services 11.7% 8.4%
Consumer Staples 5.3% 5.4%
Utilities 2.8% 2.8%
Real Estate 2.0% 1.8%
Materials 1.4% 4.0%
Energy 0.0% 4.7%
TOP 10 COUNTRIES
Country Strategy Benchmark
United States 50.2% 63.1%
United Kingdom 13.4% 3.4%
France 9.4% 2.3%
Germany 6.8% 2.0%
Japan 6.4% 5.0%
Netherlands 3.0% 1.2%
Sweden 2.1% 0.8%
China 2.1% 2.9%
South Korea 1.5% 1.8%
Italy 1.0% 0.7%
Regional Allocation
  • North America 50.2%
  • Euro 20.1%
  • Europe - Other 16.5%
  • Pacific 6.4%
  • Emerging Asia 3.6%
  • Emerging Europe, Middle East, Africa 1.0%

Commentary (As of 28 February 2026)

Highlights

  • In February, developed international and emerging markets advanced while US equities declined, with value stocks outperforming growth across all three segments.
  • In the absence of a prolonged geopolitical conflict in the Middle East, sustained earnings growth and abundant global liquidity could lift global equity market levels into 2026. While inflation progress remains uneven, G-7 central banks face mounting political and economic pressure to prioritize growth, suggesting an accommodative bias in monetary policy.
  • As leadership broadens across global equity markets, we see an expanding opportunity set for disciplined, valuation-based active management.

Portfolio Attribution

The Fund outperformed the Index during the month, due primarily to country allocation (a byproduct of our bottom-up stock selection process). Fund holdings in the semiconductors & semi equipment and pharmaceuticals & biotechnology industry groups, as well as an underweight position in the consumer discretionary distribution & retail industry group, contributed to relative performance. Holdings in the materials, commercial & professional services, and banks industry groups offset some of the outperformance compared to the Index. The top contributor to return was electronic equipment manufacturer, Samsung Electronics Co., Ltd. (South Korea). Other notable contributors included semiconductor company, Renesas Electronics Corp.(Japan), and pharmaceutical company, AstraZeneca PLC (United Kingdom). The largest detractor was technology consulting and outsourcing company, Cognizant Technology Solutions Corp. (United States). Additional notable detractors included paper -based packaging solutions company, Graphic Packaging Holding Co. (United States), and online services company, Tencent Holdings Ltd. (China).

Investment Outlook

In the absence of a prolonged geopolitical conflict in the Middle East, sustained earnings growth and abundant global liquidity could lift global equity market levels into 2026. While inflation progress remains uneven, G-7 central banks face mounting political and economic pressure to prioritize growth, suggesting an accommodative bias in monetary policy. In the United States, assuming no material escalation in tariffs and inflation, favorable tax and regulatory conditions should underpin continued economic expansion. We expect AI-driven capital expenditures to broaden beyond graphics processing units (GPUs) into power infrastructure, data center development, cooling, and networking. Accessible credit and a less restrictive regulatory backdrop appear also likely to drive a surge in M&A activity across major developed markets, supporting both public and private asset valuations. Europe and Japan could attract increased global capital flows if deregulation efforts persist and Europe advances toward deeper single-market integration and institutional coordination. Political polarization and potential voter backlash remain risks to the pace and durability of reform in both the US and Europe, especially if inflation re-accelerates or AI-related employment concerns intensify.

With conflict-induced spikes in market volatility, stock selection remains paramount. We expect some of the portfolio’s most attractive opportunities to come from companies undergoing operational restructuring, where capable management teams can re-accelerate cash flow growth—often in currently unpopular areas such as industrials and consumer staples. In health care, we are focused on businesses with durable pricing power, established franchises, and underappreciated pipelines, viewing periodic setbacks as potential entry points. We also see improving prospects among technology laggards, particularly where we believe cyclical challenges are being misread as structural. Our research seeks to distinguish permanent impairment from temporary disruption, especially in IT Services, enterprise software, and analog semiconductors, while carefully assessing the implications of rising Chinese competition.

Periods of market volatility may lead to short-term price dislocations. As active managers, we view such volatility as both a risk to be managed and a potential opportunity to initiate or add to high-conviction positions at attractive valuations, provided our fundamental thesis remains intact.

As leadership broadens across global equity markets, we see an expanding opportunity set for disciplined, valuation-based active management. By focusing on cash flow trajectory, balance sheet strength, and management execution, we seek to identify mispriced securities where we believe long-term fundamentals are not fully reflected in current valuations.

The market commentary expresses the portfolio managers' views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and any portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. Any securities identified and described do not represent all of the securities purchased, sold or recommended for the Fund. Index returns assume reinvestment of dividends and capital gains, and assume no management, custody, transaction or other expenses. The reader should not assume that an investment in any securities identified was or will be profitable. MSCI has not approved, reviewed or produced this report, makes no express or implied warranties or representations and is not liable whatsoever for any data in the report. You may not redistribute the MSCI data or use it as a basis for other indices or investment products.

Documents

Fund information: